Sex hormones and vascular reactivity

Herz

Volumn 22, Issue 3, 1997, Pages 141-150

  Hutchison, S J ^a,b,c   Sudhir, K ^a   Chou, T M ^a   Chatterjee, K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b R L McLaughlin Foundation   (Canada)

^c UCSF Medical Center at Parnassus   (United States)

Author keywords

coronary circulation; estradiol; testosterone; vasodilation

Indexed keywords

ESTRADIOL; NITRIC OXIDE; SEX HORMONE; TESTOSTERONE;

BLOOD VESSEL REACTIVITY; CORONARY ARTERY DISEASE; HUMAN; REVIEW; VASODILATATION;

EID: 0030825295     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03044351     Document Type: Review

References (106)

1. Adam, S., V. Williams, M. P. Vessey: Cardiovascular disease and hormone replacement treatment: a pilot case-control study. Brit, med. J. (Clin. Res. Ed.) 282 (1981), 1277-1278.
2. Adams, M. R., J. R. Kaplan, S. B. Manuck et al.: Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis 10 (1990), 1051-1057.
3. Adams, M. R., J. K. Williams, T. B. Clarkson, M. J. Jayo: Effects of estrogens and progestogens on coronary atherosclerosis and osteoporosis of monkeys. Baillieres clin. Obstet. Gynaec. 5 (1991), 915-934.
4. Adams, M. R., J. K. Williams, J. R. Kaplan: Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arterioscler. Thromb. Vase Biol. 15 (1995), 562-570.
5. Ajayi, A. A , R. Mathur, P. V. Halushka: Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses (see comments). Circulation 91 (1995), 2742-2747.
6. Albertsson, P., H. Emanuelsson, I. Milsom: Short term effects of estrogen in patients with syndrome X (abstracts). Circulation 90 (1994), 1-604.
7. Bar, J., R. Tepper, J. Fuchs, Y. Pardo, S. Goldberger, J. Ovadia: The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women. Obstet. and Gynec. 81 (1993), 261-264.
8. Beard, C. M., T. E. Kottke, J. F. Annegers, D. J. Ballard: The Rochester Coronary Heart Disease Project: effect of cigarette smoking, hypertension, diabetes, and steroidal estrogen use on coronary heart disease among 40- to 59-year-old women, 1960 through 1982 (see comments). Mayo Clin. Proc. 64 (1989), 1471-1480.
9. Brown, B. G., E. Bolson, R. B. Petersen, C. D. Pierce, H. T. Dodge: The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response. Circulation 64 (1981), 1089-1097.
10. Bult, H., H. R. Fret, F. H. Jordacns, A. G. Herman: Dipyridamole potentiates the anti-aggregating and vasodilator activity of nitric oxide. Europ. J. Pharmacol. 199 (1991), 1-8.
11. Burch, J. C., B. I. Byrd, W. K. Vaughn: The effects of long-term estrogen on hysterectomized women. Amer. J. Obstet. Gynec. 118 (1974), 778-782.
12. Bush, T., V. Miller: Effects of pharmacological agents used during menopause: impact on lipids and lipoproteins. In: Physiology and Pharmacology. Year Book Medical Publishers, Chicago 1987, p. 187-208.
13. Chou, T., K. Sudhir, T. Amidon, P. Collins, P. Yock, K. Chatterjee: Coronary vascular relaxation induced by testosterone in vivo is gender independent (abstract). J. Amer. Coll. Cardiol. 33A (1995), 901-116.
14. Clarkson, T. B., R. W. Prichard, T. M. Morgan, G. S. Petrick, K. P. Klein: Remodeling of coronary arteries in human and nonhuman primates (see comments). J. Amer. med. Ass. 271 (1994), 289-294.
15. Collins, P., G. M. Rosano, C. Jiang, D. Lindsay, P. M. Sarrel, W. P. Poole: Cardiovascular protection by oestrogen - a calcium antagonist effect? Lancet 341 (1993), 1264-1265.
16. Collins, P., G. Rosano, P. Sarrel et al.: 17beta-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 92 (1995), 24-30.
17. Collins, P., J. Shay, C. Jiang, J. Moss: Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation 90 (1994), 1964-1968.
18. DeGraaf, J. C., J. D. Banga, S. Moncada, R. M. Palmer et al.: Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 85 (1992), 2284-2290.
19. Dufy, B., L. Dufy-Barbe: Cell biology of hypothalamic neurosecretion. In: Vincent, J., C. Kordon (eds.): Centre National de la Recherche Scientifique, Paris 1978, p. 207-220.
20. Dufy, B., J. D. Vincent, H. Fleury, P. P. Du, D. Gourdji, V. A. Tixier: Membrane effects of thyrotropin-releasing hormone and estrogen shown by intracellular recording from pituitary cells. Science 204 (1979), 509-511.
21. Edwards, E., J. Hamilton, S. Duntley: Testosterone propionate as a therapeutic agent in patients with organic disease of peripheral vessels. New Engl. J. Med. 220 (1939), 865.
22. Evans, R. M.: The steroid and thyroid hormone receptor super-family. Science 240 (1988), 889-895.
23. Gebara, O., M. Mittleman, P. Sutherlan et al.: Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation 91 (1995).
24. Gilligan, D. M., D. M. Badar, J. A. Panza, A. A. Quyyumi, R. R. Cannon: Acute vascular effects of estrogen in postmenopausal women. Circulation 90 (1994), 786-791.
25. Ginsburg, J., P. Hardiman, B. O'Reilly: Peripheral blood flow in menopausal women who have not flushes and in those who do not. Brit. med. J. 298 (1989), 1488-1490.
26. Ginsburg, J., J. Swinhoe, B. O'Reilly: Cardiovascular responses during the menopausal hot flush. Brit. J. Obstet. Gynaec. 88 (1981), 925-930.
27. Gordon, T., W. B. Kanncl, M. C. Hjortland, P. M. McNamara: Menopause and coronary heart disease. The Framingham Study. Ann. intern. Med. 89 (1978), 157-161.
28. Gruchow, H. W., A. J. Anderson, J. J. Barboriak. K. A. Sobocinski: Postmenopausal use of estrogen and occlusion of coronary arteries. Amer. Heart J. 115 (1988), 954-963.
29. Hamm, L.: Testosterone propionate in the treatment of angina pectoris. J. Clin. Endocr. 2 (1942), 325-328.
30. Hammond, C. B., F. R. Jelovsek, K. L. Lee, W. T. Creasman, R. T. Parker: Effects of long-term estrogen replacement therapy. I. Metabolic effects. Amer. J. Obstet. Gynec. 133 (1979), 525-536.
31. Han, S., H. Karaki, Y. Ouchi, M. Akishita, H. Orimo: 17beta-estradiol inhibits calcium influx and calcium release induced by thromboxane A2 in porcine coronary artery. Circulation 91 (1995), 2619-2626.
32. Harder, D. R., P. B. Coulson: Estrogen receptors and effects of estrogen on membrane electrical properties of coronary vascular smooth muscle. J. cell. Physiol. 100 (1979), 375-382.
33. Hassager, C., B. J. Riis, V. Strom, T. T. Guyene, C. Christiansen: The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation 76 (1987), 753-758.
34. Hayashi, T., J. M. Fukuto, L. J. Ignarro, G. Chaudhuri: Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc. nat. Acad. Sci. (Wash.) 89 (1992), 11259-11263.
35. Henderson, B. E., H. A. Paganini, R. K. Ross: Estrogen replacement therapy and protection from acute myocardial infarction [published erratum appears in Amer. J. Obstet. Gynec. 159 (1988), 1574]. Amer. J. Obstet. Gynec. 159 (1988), 312-317.
36. Hernandez, A. M., A. M. Walker, H. Jick: Use of replacement estrogens and the risk of myocardial infarction. Epidemiology 1 (1990), 128-133.
37. Herrington, D., G. Braden, T. Downes, J. Williams: Estrogen modulates coronary vasomotor responses in postmenopausal women with early atherosclerosis (abstract). Circulation 90 (1994), I-619.
38. Hunt, K., M. Vessey, K. McPherson, M. Coleman: Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Brit. J. Obstet. Gynaec. 94 (1987), 620-635.
39. Hutchison, S., T. Chou, R. Seivers et al.: Testosterone, but not estradiol, attenuates acetylcholine induced relaxation to tobacco smoke exposed hypercholesterolemic rabbit aorta (abstract). J. Amer. Coll. Cardiol. (1996).
40. Hutchison, S., R. Sievers, B. Zhu et al.: Physiologic concentrations of testosterone impair endothelium-dependent vasorelaxation in hypercholesterolemic rabbits exposed to tobacco smoke. Circulation 92 (1995), I-68.
41. Iversen, L. L.: Catecholamine uptake processes. Brit. med. Bull. 29 (1973), 130-135.
42. Jiang, C, W. P. Poole, P. M. Sarrel, S. Mochizuki, P. Collins, K. T. MacLeod: Effect of 17 beta-oestradiol on contraction. Ca2+ current and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes. Brit. J. Pharmacol. 106 (1992), 739-745.
43. Jiang, C. W., P. M. Sarrel, D. C. Lindsay, W. P. Poole, P. Collins: Endothelium-independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro. Brit. J. Pharmacol. 104 (1991), 1033-1037.
44. Jiang, C., P. M. Sarrel, W. P. Poole, P. Collins: Acute effect of 17 beta-estradiol on rabbit coronary artery contractile responses to endothelin-1. Amer. J. Physiol. 263 (1997), H271-275.
45. Kakuta, T., J. W. Currier, C. C. Haudenschild, T. J. Ryan, D. P. Faxon: Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation 89 (1994), 2809-2815.
46. Keaney, J. J., G. T. Shwaery, A. Xu et al.: 17 beta-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation 89 (1994), 2251-2259.
47. Koller, A., A. Huang: Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats. Circulat. Res. 74 (1994), 416-421.
48. La, V C.: Sex hormones and cardiovascular risk. Hum. Reprod. 7 (1992), 162-167.
49. Lafferty, F. W., D. O. Helmuth: Post-menopausal estrogen replacement: the prevention of osteoporosis and systemic effects. Maturitas 7 (1985), 147-159.
50. Lefroy, D. C., T. Crake, N. G. Uren, G. J. Davies. A. Maseri: Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans (see comments). Circulation 88 (1993), 43-54.
51. Lesser, M. A.: Testosterone propionate therapy in one hundred cases of angina pectoris. J. clin. Endocr. 6 (1946), 549-557.
52. Lesser, M.: The treatment of angina pectoris with testosterone propionate. Further observation. New Engl. J. Med. 228 (1943), 185-188.
53. Levine, S., W. Likoff: The therapeutic value of testosterone propionate in angina pectoris. New Engl. J. Med. 228 (1943), 770-772.
54. MacKenzie, J.: Irritation of the sexual apparatus. Amer. J. med. Sci. 87 (1884), 360.
55. MacMahon, B.: Cardiovascular disease and noncontraceptive oestrogen therapy. In: Oliver, M. (ed.): Coronary heart disease in young women. Churchill Livingstone, Edinburgh 1978.
56. McFarland, K. F., M. E. Boniface, C. A. Hornung, W. Earnhardt, J. O. Humphries: Risk factors and noncontraceptive estrogen use in women with and without coronary disease. Amer. Heart J. 117 (1989), 1209-1214.
57. McLenachan, J. M., J. K. Williams, R. D. Fish, P. Ganz, A. P. Selwyn: Loss of flow-mediated endothelium-dependent dilation occurs early in the development of atherosclerosis. Circulation 84 (1991), 1273-1278.
58. McPherson, D. D., M. R. Johnson, N. M. Alvarez et al.: Variable morphology of coronary atherosclerosis: characterization of atherosclerotic plaque and residual arterial lumen size and shape by epicardial echocardiography. J. Amer. Coll. Cardiol. 19 (1992), 593-599.
59. Meller, J., A. Pichard, S. Dack: Coronary arterial spasm in Prinzmetal's angina: a proved hypothesis. Amer. J. Cardiol. 37 (1976), 938-940.
60. Moncada, S.: The 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway. Acta physiol. scand. 145 (1992), 201-227.
61. Moncada, S., A. Higgs: The L-arginine-nitric oxide pathway. New Engl. J. Med. 329 (1993), 2002-2012.
62. Mugge, A., M. Riedel, M. Barton, M. Kuhn, P. R. Lichtler: Endothelium independent relaxation of human coronary arteries by 17 beta-oestradiol in vitro. Cardiovasc. Res. 27 (1993), 1939-1942.
63. Nabulsi, A. A., A. R. Folsom, A. White et al.: Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The atherosclerosis risk in communities study investigators (see comments). New Engl. J. Med. 328 (1993), 1069-1075.
64. Nachtigall, L. E., R. H. Nachtigall, R. D. Nachtigall, E. M. Beckman: Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet, and Gynec. 54 (1979), 74-79.
65. Petitti, D. B., J. A. Perlman, S. Sidney: Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study. Obstet, and Gynec. (1987), 289-293.
66. Pietras, R. J., C. M. Szego: Endometrial cell calcium and oestrogen action. Nature (Lond.) 253 (1975), 357-359.
67. Pietras, R. J., C. M. Szego: Specific binding sites for oestrogen of the outer surfaces of isolated endometrial cells. Nature (Lond.) 265 (1977), 69-72.
68. Polderman, K. H., C. D. Stehouwer, G. van Kamp, G. A. Dekker, F. W. Verheugt, L. J. Gooren: Influence of sex hormones on plasma endothelin levels. Ann. intern Med. 118 (1993), 429-432.
69. Reis, S. E., S. T. Gloth, R. S. Blumenthal et al.: Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 89 (1994), 52-60.
70. Reis, S., S. Gloth, R. Blumenthal, H. Zacur: The influence of chronic estrogen replacement therapy on the acute affects of intravenous ethinyl estradiol on coronary artery flow in post-menopausal women (abstract). J. Amer. Coll. Cardiol. 21 (1993), 702-706.
71. Rhee, C. Y., T. H. Spaet, M. B. Stemerman et al.: Estrogen suppression of surgically induced vascular intimai hyperplasia in rabbits. J. Lab. clin. Med. 90 (1977), 77-84.
72. Rosano, G., D. Lefroy, N. Peters et al.: Symptomatic response to 17-beta-estradiol in women with Syndrome X. J. Amer. Coll. Cardiol. 22 (1994), 702.
73. Rosano, G. M., P. M. Sarrel, W. P. Poole, P. Collins: Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease (see comments). Lancet 342 (1993), 133-136.
74. Rosenberg, L., B. Armstrong, H. Jick: Myocardial infarction and estrogen therapy in post-menopausal women. New Engl. J. Med. 294 (1976), 1256-1259.
75. Saner, H. E., F. L. Gobel, E. Salomonowitz, D. A. Erlien, J. E. Edwards: The disease-free wall in coronary atherosclerosis: its relation to degree of obstruction. J. Amer. Coll. Cardiol. 6 (1985), 1096-1099.
76. Schaeffer, J. M., S. Stevens, R. G. Smith, A. J. Hsueh: Binding of 2-hydroxyestradiol to rat anterior pituitary cell membranes. J. biol Chem. 255 (1980), 9838-9843.
77. Schror, K., T. A. Morinelli, A. Masuda, K. Matsuda, R. S. Mathur, P. V. Halushka: Testosterone treatment enhances thromboxane A2 mimetic induced coronary artery vasoconstriction in guinea pigs. Europ. J. clin. Invest. 1 (1994), 50-52.
78. Sigler, L. H., J. Tulgan: Treatment of angina pectoris by testosterone propionate. N. Y. St. J. Med. 43 (1943), 1424-1428.
79. Sigler, L., J. Tulgan: Treatment of angina pectoris by testosterone propionate, N. Y. St. J. Med. 43 (1943), 1424-1428.
80. Szklo, M., J. Tonascia, L. Gordis, I. Bloom: Estrogen use and myocardial infarction risk: a case-control study. Prev. Med. 13 (1984), 510-516.
81. Stamler, J. S., E. Loh, M. A. Roddy, K. E. Currie, M. A. Creager: Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89 (1994), 2035-2040.
82. Stamler, J., R. Pick, L. Katz: Experience in assessing estrogen antiatherogenesis in the chick, the rabbit and man. Ann. N. Y. Acad. Sci. 64 (1956), 596-619.
83. Stampfer, M. J., G. A. Colditz, W. C. Willett et al.. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study (see comments). New Engl. J. Med. 325 (1991), 756-762.
84. Stampfer, M. J., W. C. Willett, G. A. Colditz, B. Rosner, F. E. Speizer, C. H. Hennekens: A prospective study of postmenopausal estrogen therapy and coronary heart disease. New Engl. J. Med. 313 (1985), 1044-1049.
85. Sudhir, K. T. Chou, W. Mullen, P. Collins, P. Yock, K. Chatterjee: Role of calcium channel and alpha-adrenoreceptor antagonism in estrogen-induced vasodilation in canine conductance and resistance arteries (abstract). J. Amer. Coll. Cardiol. 22 (1994), 211A.
86. Sudhir, K., T. M. Chou, W. L. Mullen et al.: Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries. J. Amer. Coll. Cardiol. 26 (1995), 807-814.
87. Sullivan, J. M., Z. R. Vander, G. F. Lemp et al.: Postmenopausal estrogen use and coronary atherosclerosis. Ann. intern. Med. 108 (1988), 358-363.
88. Talbott, E., L. H. Kuller, K. Detre, J. Perper: Biologic and psychosocial risk factors of sudden death from coronary disease in white women. Amer. J. Cardiol. 39 (1977), 858-864.
89. Tschudi, M., V. Richard, F. R. Buhler, T. F. Luscher: Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries. Amer. J. Physiol. (1991), H13-20.
90. Van Buren, G., D. S. Yang, K. E. Clark: Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Amer. J. Obstet. Gynec. 167 (1992), 828-833.
91. Vargas, R., B. Wroblewska, A. Rego, J. Hatch, P. W. Ramwell: Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Brit. J. Pharamcol. 109 (1993), 612-617.
92. Wagner, J. D., M. R. Adams, D. C. Schwenke, T. B. Clarkson: Oral contraceptive treatment decreases arterial low density lipoprotein degradation in female cynomolgus monkeys. Circulat. Res. 72 (1993), 1300-1307.
93. Wagner, J. D., T. B. Clarkson, C. R. St, D. C. Schwenke, C. A. Shively, M. R. Adams: Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J. clin. Invest. 88 (1991), 1995-2002.
94. Waller, B. F.: The eccentric coronary atherosclerotic plaque: morphologic observations and clinical relevance. Clin. Cardiol. 12 (1989), 14-20.
95. Walsh, B. W., I. Schiff, B. Rosner, L. Greenberg, V. Ravnikar, F. M. Sacks: Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins (see comments). New Engl. J. Med. 325 (1991), 1196-1204.
96. Wehling, M., M. Christ, K. Theisen: Membrane receptors for aldosterone: a novel pathway for mineralocorticoid action. Amer. J. Physiol. (1992), E974-979.
97. Wehling, M., J. Kasmayr, K. Theisen: Rapid effects of mineralocorticoids on sodium-proton exchanger: genomic or nongenomic pathway? Amer. Physiol. (1991), E719-726.
98. Weiner, C. P., I. Lizasoain, S. A. Baylis, R. G. Knowles, I. G. Charles, S. Moncada: Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc. nat. Acad. Sci. (Wash.) 91 (1994), 5212-5216.
99. Welfare DoHEa: The Framingham Study, 1974.
100. Williams, J. K., M. R. Adams, D M. Herrington, T. B. Clarkson: Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries (see comments). J. Amer. Coll. Cardiol. 20 (1992), 452-457.
101. Williams, J. K., M. R. Adams, H. S. Klopfenstein: Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81 (1990), 1680-1687.
102. Williams, J. K., E. K. Honore, S. A. Washburn, T. B. Clarkson: Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J. Amer. Coll. Cardiol. 24 (1994), 1757-1761.
103. Williams, J. K., C. A. Shively, T. B. Clarkson: Determinants of coronary artery reactivity in premenopaual female cynomolgus monkeys with diet-induced atherosclerosis. Circulation 90 (1994), 983-987.
104. The Writing Group for the PEPI Trial: Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. J. Amer. med. Ass. 273 (1995), 199-208.
105. Wu, S. Z., X. Z. Weng: Therapeutic effects of an androgenic preparation on myocardial ischemia and cardiac function in 62 elderly male coronary heart disease patients. Chin. med. J. 106 (1993), 415-418.
106. Yue, P., K. Chatterjee, C. Beale, W. P. Poole, P. Collins: Testosterone relaxes rabbit coronary arteries and aorta. Circulation 91 (1995), 1154-1160.